Component

Kynurenine-derived trace extended aromatic condensation products / TEACOPs

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Purified kynurenine-derived TEACOPs activated mouse AHR at low picomolar concentrations in the reported assays.

    Experimental context and source evidence
    evidence_access
    Primary abstract and primary full text, Figure 1 and receptor constructs
    experimental_model
    Mouse AHR constructs in chemical pharmacology experiments.
    limitations
    Mouse receptor evidence must not be silently converted into a measured human physiological concentration.
    nutrient_topic
    Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
    plain_language
    Tiny amounts of a derivative can change receptor signaling.
    primary_references
    Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). · 2018 · https://pubmed.ncbi.nlm.nih.gov/29279331/ · DOI 10.1074/jbc.RA117.000631

    Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 442–448

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse AHR constructs in chemical pharmacology experiments. · source_derived_draft · unverified_draft

    ## tryptophan-teacop-ahr Tiny amounts of a derivative can change receptor signaling. Purified kynurenine-derived TEACOPs activated mouse AHR at low picomolar concentrations in the reported assays. Model: Mouse AHR constructs in chemical pharmacology experiments. Limitations: Mouse receptor evidence must not be silently converted into a measured human physiological concentration. Evidence access: Primary abstract and primary full text, Figure 1 and receptor constructs Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). · 2018 · https://pubmed.ncbi.nlm.nih.gov/29279331/ · DOI 10.1074/jbc.RA117.000631
    Complete structured claim and evidence

What acts on it

  1. Incubation or storage increased kynurenine-solution AHR potency by 100–1000-fold; isolated trace condensation products accounted for potent activity.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Chemical purification, synthesis and mouse-AHR reporter/ligand-pocket experiments.
    limitations
    Does not quantify TEACOP concentrations in human tumors or prove every kynurenine-associated effect is caused by these products.
    nutrient_topic
    Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
    plain_language
    What forms from a metabolite in solution can matter more than the nominal starting compound.
    primary_references
    Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). · 2018 · https://pubmed.ncbi.nlm.nih.gov/29279331/ · DOI 10.1074/jbc.RA117.000631

    Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 434–440

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Chemical purification, synthesis and mouse-AHR reporter/ligand-pocket experiments. · source_derived_draft · unverified_draft

    ## tryptophan-teacop-formation What forms from a metabolite in solution can matter more than the nominal starting compound. Incubation or storage increased kynurenine-solution AHR potency by 100–1000-fold; isolated trace condensation products accounted for potent activity. Model: Chemical purification, synthesis and mouse-AHR reporter/ligand-pocket experiments. Limitations: Does not quantify TEACOP concentrations in human tumors or prove every kynurenine-associated effect is caused by these products. Evidence access: Primary abstract Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). · 2018 · https://pubmed.ncbi.nlm.nih.gov/29279331/ · DOI 10.1074/jbc.RA117.000631
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards